Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Your confirmation email is on its way. Please check your inbox for further instructions.

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daxor Co. stock logo
DXR
Daxor
$9.69
+1.5%
$9.25
$7.11
$10.15
$45.93M-0.453,255 shs462 shs
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
$0.05
-17.5%
$0.07
$0.03
$1.25
$1.90M0.0480,180 shs24,308 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$19.30
-1.0%
$18.14
$14.51
$22.99
$66.01M0.558,237 shs4,263 shs
Titan Medical Inc. stock logo
TMDI
Titan Medical
$0.14
-26.3%
$0.23
$0.13
$1.20
$15.67M2.364.83 million shs7.71 million shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daxor Co. stock logo
DXR
Daxor
0.00%-0.03%-2.05%+9.77%+954,999,900.00%
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
0.00%+83.28%-32.22%-31.33%-91.36%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.00%+4.78%+2.63%+10.42%+10.98%
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/AN/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
2.3124 of 5 stars
3.50.00.04.50.01.70.0
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
3.00
Buy$2.505,219.15% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
$3.02K628.62N/AN/A($0.41) per share-0.11
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.09M1.43$2.22 per share8.70$8.91 per share2.17
Titan Medical Inc. stock logo
TMDI
Titan Medical
$20.09M0.78N/AN/A$0.32 per share0.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Daxor Co. stock logo
DXR
Daxor
N/AN/A0.00N/AN/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
-$14.14M-$0.39N/AN/AN/AN/A-142.69%N/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.5833.28N/A4.13%6.50%4.01%10/11/2024 (Estimated)
Titan Medical Inc. stock logo
TMDI
Titan Medical
-$14.86M-$0.19N/AN/AN/A-167.03%-112.15%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/A
0.19
0.03
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.25
3.45
2.08
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/A
1.41
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Daxor Co. stock logo
DXR
Daxor
1.34%
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
4.41%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Titan Medical Inc. stock logo
TMDI
Titan Medical
3.55%

Insider Ownership

CompanyInsider Ownership
Daxor Co. stock logo
DXR
Daxor
60.60%
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
41.60%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.02%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Daxor Co. stock logo
DXR
Daxor
N/A4.74 million1.87 millionNot Optionable
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
3640.35 million23.57 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.42 million1.96 millionNot Optionable
Titan Medical Inc. stock logo
TMDI
Titan Medical
49111.95 million111.93 millionNot Optionable

TMDI, PDEX, DXR, and NMRD Headlines

Recent News About These Companies

Titan Pharmaceuticals: Q1 Earnings Snapshot
TMD:CA Titan Medical Inc.
Titan Medical Inc TMDIF
Perifery appoints Titan Data Solutions as authorised distributor
Titan Medical Inc (TMD)
Vantage Titan 3T MRI Scanner from Toshiba
TMDIF Titan Medical Inc.
Destiny 2 best Titan build for PvE and PvP

Media Sentiment Over Time

Company Descriptions

Daxor logo

Daxor

NASDAQ:DXR
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Nemaura Medical logo

Nemaura Medical

NASDAQ:NMRD
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Titan Medical logo

Titan Medical

NASDAQ:TMDI
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.